Read More Pharma Industry News How GTx-104 may improve ICU dosing consistency in subarachnoid hemorrhage How Grace Therapeutics’ GTx-104 could improve ICU dosing consistency and reshape hospital economics in subarachnoid hemorrhage care. Read the full BNT analysis. bySoujanya RaviApril 16, 2026